$LFST
LifeStance Health Group, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023040649 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $262.9M $259.6M $209.5M
YoY Change 20.84% 23.89% 30.51%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $130.9M $101.9M $103.6M
YoY Change 61.17% -1.65% 21.15%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.448M $9.354M $6.750M
YoY Change 23.02% 38.58% 119.87%
% of Gross Profit
Operating Expenses $337.3M $308.0M $270.0M
YoY Change 31.53% 14.07% 30.06%
Operating Profit -$74.36M -$48.41M -$60.47M
YoY Change 91.45% -19.94% 28.54%
Interest Expense $5.477M $5.119M $7.133M
YoY Change 30.75% -28.23% -69.22%
% of Operating Profit
Other Income/Expense, Net -$3.611M -$3.607M -$7.332M
YoY Change 7.25% -50.8% -72.62%
Pretax Income -$77.97M -$52.02M -$67.80M
YoY Change 84.73% -23.28% -8.15%
Income Tax -$16.39M -$6.542M $923.0K
% Of Pretax Income
Net Earnings -$61.58M -$45.48M -$68.73M
YoY Change 62.69% -33.83% -1.86%
Net Earnings / Revenue -23.42% -17.52% -32.8%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.17 -$0.13 -$194.3K
COMMON SHARES
Basic Shares Outstanding 378.0M 376.8M 353.7K
Diluted Shares Outstanding 372.5K 363.2K 353.7K

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.60M $79.61M $96.69M
YoY Change -52.84% -17.67% -64.99%
Cash & Equivalents $42.61M $79.61M $96.69M
Short-Term Investments
Other Short-Term Assets $71.90M $36.48M $47.86M
YoY Change 46.83% -23.78% 72.13%
Inventory
Prepaid Expenses
Receivables $149.7M $121.8M $99.74M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $264.3M $237.9M $244.3M
YoY Change 4.62% -2.62% -32.9%
LONG-TERM ASSETS
Property, Plant & Equipment $190.1M $193.1M $190.7M
YoY Change -1.72% 1.28% 107.73%
Goodwill $1.293B $1.294B $1.244B
YoY Change 3.49% 4.0% 9.22%
Intangibles $233.6M $243.8M $282.1M
YoY Change -14.26% -13.58% -10.88%
Long-Term Investments
YoY Change
Other Assets $13.02M $11.22M $7.888M
YoY Change 14.08% 42.25% 139.03%
Total Long-Term Assets $1.911B $1.933B $1.724B
YoY Change 10.64% 12.1% 11.22%
TOTAL ASSETS
Total Short-Term Assets $264.3M $237.9M $244.3M
Total Long-Term Assets $1.911B $1.933B $1.724B
Total Assets $2.175B $2.171B $1.969B
YoY Change 9.87% 10.27% 2.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.40M $8.044M $12.94M
YoY Change 30.87% -37.84% 29.96%
Accrued Expenses $218.3M $158.9M $87.42M
YoY Change 140.21% 81.8% -1.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.595M $2.595M $1.500M
YoY Change 20.98% 73.0% -7.35%
Total Short-Term Liabilities $240.9M $180.9M $111.5M
YoY Change 114.55% 62.14% -0.9%
LONG-TERM LIABILITIES
Long-Term Debt $248.4M $248.7M $203.4M
YoY Change 17.13% 22.3% 29.48%
Other Long-Term Liabilities $855.0K $2.559M $64.54M
YoY Change -98.72% -96.03% 310.97%
Total Long-Term Liabilities $479.1M $495.2M $325.8M
YoY Change 42.65% 51.97% 26.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $240.9M $180.9M $111.5M
Total Long-Term Liabilities $479.1M $495.2M $325.8M
Total Liabilities $720.0M $676.0M $437.4M
YoY Change 60.66% 54.57% 18.28%
SHAREHOLDERS EQUITY
Retained Earnings -$715.9M -$654.3M -$488.1M
YoY Change 36.11% 34.04% 279.6%
Common Stock $2.167B $2.145B $2.019B
YoY Change 5.46% 6.22% 20.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.455B $1.495B $1.531B
YoY Change
Total Liabilities & Shareholders Equity $2.175B $2.171B $1.969B
YoY Change 9.87% 10.27% 2.83%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$61.58M -$45.48M -$68.73M
YoY Change 62.69% -33.83% -1.86%
Depreciation, Depletion And Amortization $9.448M $9.354M $6.750M
YoY Change 23.02% 38.58% 119.87%
Cash From Operating Activities -$25.36M -$434.0K $7.833M
YoY Change -542.58% -105.54% -146.31%
INVESTING ACTIVITIES
Capital Expenditures $9.800M $11.58M -$25.87M
YoY Change -164.92% -144.77% 24.82%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$12.17M
YoY Change -100.0% -100.0% -68.28%
Cash From Investing Activities -$9.800M -$11.58M -$38.04M
YoY Change -51.66% -69.55% -35.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.850M 23.33M 12.90M
YoY Change -122.58% 80.81% -95.87%
NET CHANGE
Cash From Operating Activities -25.36M -434.0K 7.833M
Cash From Investing Activities -9.800M -11.58M -38.04M
Cash From Financing Activities -1.850M 23.33M 12.90M
Net Change In Cash -37.01M 11.31M -17.30M
YoY Change 482.83% -165.37% -107.31%
FREE CASH FLOW
Cash From Operating Activities -$25.36M -$434.0K $7.833M
Capital Expenditures $9.800M $11.58M -$25.87M
Free Cash Flow -$35.16M -$12.02M $33.70M
YoY Change -268.83% -135.65% 785.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Cost And Expense Related And Nonrelated Party Status Extensible Enumeration
OperatingCostAndExpenseRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Operating Cost And Expense Related And Nonrelated Party Status Extensible Enumeration
OperatingCostAndExpenseRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
dei Entity Central Index Key
EntityCentralIndexKey
0001845257
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40478
dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 6000
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
dei City Area Code
CityAreaCode
602
dei Local Phone Number
LocalPhoneNumber
767-2100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
LFST
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
495187000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
479149000
CY2023Q2 us-gaap Liabilities
Liabilities
676041000
CY2022Q4 us-gaap Liabilities
Liabilities
655148000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
378005241
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79605000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108621000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
121796000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100868000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36480000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23734000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
237881000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
233223000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193144000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
194189000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
191381000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
199431000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
243788000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
263294000
CY2023Q2 us-gaap Goodwill
Goodwill
1293502000
CY2022Q4 us-gaap Goodwill
Goodwill
1272939000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11221000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10795000
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1933036000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1940648000
CY2023Q2 us-gaap Assets
Assets
2170917000
CY2022Q4 us-gaap Assets
Assets
2173871000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8044000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12285000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
81144000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
75650000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
34348000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30428000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10537000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
15876000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43446000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38824000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3335000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2936000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
180854000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
175999000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
248718000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
225079000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
205586000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
212586000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38324000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38701000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2559000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2783000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
378005000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
378005000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
375964000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
375964000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
3782000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3761000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2141247000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2084324000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4151000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3274000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-654304000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-572636000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1494876000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1518723000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2170917000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2173871000
CY2023Q2 us-gaap Revenues
Revenues
259578000
CY2022Q2 us-gaap Revenues
Revenues
209527000
us-gaap Revenues
Revenues
512167000
us-gaap Revenues
Revenues
412622000
CY2023Q2 us-gaap Other General Expense
OtherGeneralExpense
186607000
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
149697000
us-gaap Other General Expense
OtherGeneralExpense
369594000
us-gaap Other General Expense
OtherGeneralExpense
298590000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101854000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103559000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
186480000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
206928000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19530000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16743000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
38599000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32427000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
307991000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
269999000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
363161
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
353729
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
353729
us-gaap Operating Expenses
OperatingExpenses
594673000
us-gaap Operating Expenses
OperatingExpenses
537945000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-48413000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-60472000
us-gaap Operating Income Loss
OperatingIncomeLoss
-82506000
us-gaap Operating Income Loss
OperatingIncomeLoss
-125323000
CY2023Q2 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
1539000
CY2022Q2 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-180000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
2576000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-614000
CY2023Q2 lfst Transaction Costs
TransactionCosts
3000
CY2022Q2 lfst Transaction Costs
TransactionCosts
19000
lfst Transaction Costs
TransactionCosts
89000
lfst Transaction Costs
TransactionCosts
297000
CY2023Q2 us-gaap Interest Expense
InterestExpense
5119000
CY2022Q2 us-gaap Interest Expense
InterestExpense
7133000
us-gaap Interest Expense
InterestExpense
10211000
us-gaap Interest Expense
InterestExpense
10574000
CY2023Q2 us-gaap Other Expenses
OtherExpenses
24000
CY2022Q2 us-gaap Other Expenses
OtherExpenses
0
us-gaap Other Expenses
OtherExpenses
69000
us-gaap Other Expenses
OtherExpenses
0
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3607000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7332000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7793000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11485000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52020000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67804000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90299000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-136808000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6542000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
923000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10579000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5753000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-45478000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-68727000
us-gaap Net Income Loss
NetIncomeLoss
-79720000
us-gaap Net Income Loss
NetIncomeLoss
-131055000
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.19
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.19
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.37
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
363161
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
362039
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
362039
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
352297
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
352297
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-45478000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-614000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2708000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-68727000
us-gaap Net Income Loss
NetIncomeLoss
-79720000
us-gaap Net Income Loss
NetIncomeLoss
-131055000
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
2147000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
877000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43331000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68727000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78843000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-131055000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1505129000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-45478000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-34000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2147000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33112000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1494876000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1542518000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-68727000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57510000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1531301000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1518723000
us-gaap Net Income Loss
NetIncomeLoss
-79720000
lfst Adoption Of Asu Two Zero One Six To One Three
AdoptionOfAsuTwoZeroOneSixToOneThree
-1948000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3399000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
877000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60343000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1494876000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1545028000
us-gaap Net Income Loss
NetIncomeLoss
-131055000
lfst Stock Issued During Period Value Restricted Stock Units Releases
StockIssuedDuringPeriodValueRestrictedStockUnitsReleases
-37000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-185000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
117550000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1531301000
us-gaap Profit Loss
ProfitLoss
-79720000
us-gaap Profit Loss
ProfitLoss
-131055000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
38599000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32427000
lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
20263000
lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
0
us-gaap Share Based Compensation
ShareBasedCompensation
56944000
us-gaap Share Based Compensation
ShareBasedCompensation
117365000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3380000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1076000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
748000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
2576000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20558000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21900000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15176000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5351000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5395000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1731000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
5158000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-289000
lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-16929000
lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
7282000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
13471000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8324000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11141000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19310000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53775000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19820000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
35118000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39130000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88893000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
25000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
228000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
188000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7184000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1173000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
181230000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
1609000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5201000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
11090000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
478000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18438000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26409000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29016000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51343000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108621000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148029000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79605000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96686000
us-gaap Interest Paid Net
InterestPaidNet
9830000
us-gaap Interest Paid Net
InterestPaidNet
4927000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
313000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
860000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
256000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
1985000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
5683000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12477000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
6238000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
13055000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Accounting Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q2 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2023Q2 lfst Common Stock Held By Non Affiliates
CommonStockHeldByNonAffiliates
700000000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
259578000
CY2023Q2 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
209527000
CY2022Q2 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
512167000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
412622000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
251491000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
237072000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58347000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42883000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193144000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
194189000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9354000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6750000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18250000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
14264000
us-gaap Operating Lease Cost
OperatingLeaseCost
28572000
us-gaap Variable Lease Cost
VariableLeaseCost
0
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0677
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0647
us-gaap Operating Lease Payments
OperatingLeasePayments
30995000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14554000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
25987000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
64960000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
61345000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
53713000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
40457000
CY2023Q2 lfst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
49810000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
296272000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
47240000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
249032000
CY2022Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
12528000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
24074000
CY2022Q4 us-gaap Goodwill
Goodwill
1272939000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
20733000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-170000
CY2023Q2 us-gaap Goodwill
Goodwill
1293502000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
366729000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
122941000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
243788000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
365886000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
102592000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
263294000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10176000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9993000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20349000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19950000
CY2022Q2 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
4
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
3
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
6
CY2023Q2 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
0
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
430000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
181000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
851000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
707000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
372000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
1193000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
166000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
138000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
230000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
19000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
221000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
53000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
0
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
368000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
0
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
53000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
22000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
56000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
901000
lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
1985000
CY2022 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
11221000
lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-5201000
CY2022 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-12515000
lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-2576000
CY2022 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
1688000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
843000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
1683000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
14526000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
20733000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
39227000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
16802000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
22878000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
43293000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
989000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
893000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
1685000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
15813000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
21985000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
41608000
CY2022Q2 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
901000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
843000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
1683000
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
62632000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
4426000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17430000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
12032000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
12032000
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
17824000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
257791000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
233964000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2595000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2345000
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6478000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6540000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
248718000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
225079000
CY2023Q2 us-gaap Interest Expense
InterestExpense
5119000
CY2022Q2 us-gaap Interest Expense
InterestExpense
7133000
us-gaap Interest Expense
InterestExpense
10211000
us-gaap Interest Expense
InterestExpense
10574000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
1298000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2595000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2595000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2595000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
2595000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
246113000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
257791000
CY2023Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
262681000
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
235049
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5753000
CY2023Q2 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
33078000
CY2022Q2 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
57510000
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
56944000
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
117365000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
199683
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6542000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
923000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10579000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.126
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.014
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.117
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.042
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
3000000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
8000000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45478000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-68727000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79720000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-131055000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
363161
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
353729
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
362039
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
352297
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.19
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.19
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.37
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45021
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34075
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-040649-index-headers.html Edgar Link pending
0000950170-23-040649-index.html Edgar Link pending
0000950170-23-040649.txt Edgar Link pending
0000950170-23-040649-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfst-20230630.htm Edgar Link pending
lfst-20230630.xsd Edgar Link pending
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lfst-20230630_cal.xml Edgar Link unprocessable
lfst-20230630_lab.xml Edgar Link unprocessable
lfst-20230630_pre.xml Edgar Link unprocessable
lfst-20230630_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lfst-20230630_def.xml Edgar Link unprocessable